Nonpeptidic propargylamines as inhibitors of lysine specific demethylase 1 (LSD1) with cellular activity.

Lysine demethylases play an important role in epigenetic regulation and thus in the development of diseases like cancer or neurodegenerative disorders. As the lysine specific demethylase 1 (LSD1/KDM1) has been strongly connected to androgen and estrogen dependent gene expression, it serves as a promising target for the therapy of hormone dependent cancer. Here, we report on the discovery of new small molecule inhibitors of LSD1 containing a propargylamine warhead, starting out from lysine containing substrate analogues. On the basis of these substrate mimicking inhibitors, we were able to increase potency by a combination of similarity-based virtual screening and subsequent synthetic optimization resulting in more druglike LSD1 inhibitors that led to histone hypermethylation in breast cancer cells.

[1]  A. Ganesan,et al.  Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors. , 2011, Bioorganic & medicinal chemistry.

[2]  Z. Otwinowski,et al.  Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase. , 2006, Molecular cell.

[3]  S. Wetzel,et al.  Impairment of prostate cancer cell growth by a selective and reversible lysine‐specific demethylase 1 inhibitor , 2012, International journal of cancer.

[4]  Polyamine analogs modulate gene expression by inhibiting lysine-specific demethylase 1 (LSD1) and altering chromatin structure in human breast cancer cells , 2012, Amino Acids.

[5]  A. Giannis,et al.  Epigenetics--an epicenter of gene regulation: histones and histone-modifying enzymes. , 2005, Angewandte Chemie.

[6]  S. Baylin,et al.  Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes , 2007, Proceedings of the National Academy of Sciences.

[7]  Min Gyu Lee,et al.  Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. , 2006, Chemistry & biology.

[8]  Takayoshi Suzuki,et al.  Lysine demethylases inhibitors. , 2011, Journal of medicinal chemistry.

[9]  Bing Li,et al.  The Role of Chromatin during Transcription , 2007, Cell.

[10]  Makoto Hasegawa,et al.  Identification of cell-active lysine specific demethylase 1-selective inhibitors. , 2009, Journal of the American Chemical Society.

[11]  T. Umehara,et al.  Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 A. , 2008, Biochemical and biophysical research communications.

[12]  P. Cole,et al.  A mechanism-based inactivator for histone demethylase LSD1. , 2006, Journal of the American Chemical Society.

[13]  P. Cole,et al.  LSD1 and the chemistry of histone demethylation. , 2007, Current opinion in chemical biology.

[14]  M. Machius,et al.  Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine. , 2007, Biochemistry.

[15]  A. Mai,et al.  Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2. , 2010, Journal of the American Chemical Society.

[16]  D. Ward,et al.  Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties. , 2011, Cancer research.

[17]  A. Mai,et al.  Screening Assays for Epigenetic Targets Using Native Histones as Substrates , 2012, Journal of biomolecular screening.

[18]  F. Forneris,et al.  Structural Basis of LSD1-CoREST Selectivity in Histone H3 Recognition* , 2007, Journal of Biological Chemistry.

[19]  André Hoelz,et al.  Crystal structure and mechanism of human lysine-specific demethylase-1 , 2006, Nature Structural &Molecular Biology.

[20]  M. Machius,et al.  Structural basis of histone demethylation by LSD1 revealed by suicide inactivation , 2007, Nature Structural &Molecular Biology.

[21]  Yong Chen,et al.  Crystal structure of human histone lysine-specific demethylase 1 (LSD1) , 2006, Proceedings of the National Academy of Sciences.

[22]  M. Fraaije,et al.  Flavoenzymes: diverse catalysts with recurrent features. , 2000, Trends in biochemical sciences.

[23]  Antoine H. F. M. Peters,et al.  LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription , 2005, Nature.

[24]  T. Umehara,et al.  Structurally designed trans-2-phenylcyclopropylamine derivatives potently inhibit histone demethylase LSD1/KDM1 . , 2010, Biochemistry.